News

Sevuparin is an adjunctive therapy to anti-parasite medicines to prevent the infected red blood cells from obstructing blood vessels to reduce mortality. The grant from Vinnova will be

FLD causes lipid deposition in eyes, red blood cells and kidneys which can lead to corneal opacity, hemolytic anemia and kidney failure respectively. ACP-501, being developed to treat

Total revenues for third quarter of 2012 were $884.14m compared to $600.58m for the third quarter of 2011. The company reported a net loss of $26.88m, or $0.09

The open-label study of 198 patients, who have developed the syndrome during an outbreak in Germany, demonstrated significant and persistent progression in thrombotic microangiopathy (TMA) and setback of

The OncoGenomics Explorer solution will provide Bayer with a centralized access to unified global genomics data for utilization across the entire research organization from target discovery to drug

The new Sorvall LYNX centrifuge runs with 100,000 x g top speed and supports high-throughput sample processing from 50 mL conical tubes and microplates to 1 L bottles,

Health Canada asked Novartis to suspend distribution of Agriflu and Fluad on 26 October 2012 as precautionary measure. The Public Health Agency of Canada, which monitors vaccination-related adverse

The new Prena1 line products including Prena1Plus, Prena1 and Prena1 Chew contain a combination of folic acid and plant-based DHA. Prena1Plus, a single dose dietary supplement, contains one

In the financing round, its existing investor, Morningside Ventures, and New Leaf Venture Partners have participated. The company will use the capital to support commercialization of its proprietary